Washington Matters

In this episode, members of DLA Piper’s Government Affairs and Public Policy Group discuss the US Presidential election results, outlining the expected impact and outlook for key issues that could dominate the coming year.

*This episode was recorded a week after the election

See omnystudio.com/listener for privacy information.

Former Speaker of the US House of Representatives John Boehner sits down with DLA Piper’s Richard Burr to discuss the importance of bipartisan relationships, how the private sector can effectively engage Congress, and potential impacts of the upcoming US presidential election.

See omnystudio.com/listener for privacy information.

Former US Senator Richard Burr is joined by DLA Piper Partner Samantha Chaifetz and University of Michigan Professor Christopher Walker to discuss the impact of the US Supreme Court’s Loper Bright decision.

See omnystudio.com/listener for privacy information.

Senator Richard Burr and former Director of the National Security Agency and the US Cyber Command Paul Nakasone discuss lessons learned, the cybersecurity landscape, and the impact of AI and emerging technologies on national security. 

See omnystudio.com/listener for privacy information.

Duke University athletic director Nina King and University of North Carolina at Chapel Hill athletic director Bubba Cunningham join DLA Piper's Richard Burr for a wide-ranging conversation on the future of the Atlantic Coast Conference (ACC), including the issue of name, image and likeness.

See omnystudio.com/listener for privacy information.

Richard Burr, former US senator and current chair of DLA Piper’s Health Policy Strategic Consulting practice, talks with Julie Gerberding, former director of the U.S. Centers for Disease Control and Prevention (CDC) and current CEO of the Foundation for the National Institutes of Health (FNIH). The wide-ranging conversation includes thoughts on the Pandemic and All-Hazards Preparedness Act (PAHPA), lessons learned from COVID-19, and potential benefits of AI in therapeutic research and development.

See omnystudio.com/listener for privacy information.